CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family

Microbial Drug Resistance

Volumn 10, Issue 3, 2004, Pages 191-196

  Dridi, L ^a   Tankovic, J ^a   Petit, J C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; GENTAMICIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CDEA GENE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; ESCHERICHIA COLI; GENE; GENE FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CLONING, MOLECULAR; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PLASMIDS;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; ESCHERICHIA COLI;

EID: 4644306334     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2004.10.191     Document Type: Article

References (21)

1. Ackermann, G., Y.J. Tang, R. Kueper, P. Heisig, A.C. Rodloff, J. Suva Jr., and S.H. Cohen. 2001. Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob. Agents Chemother. 45:2348-2353.
2. Andersen, B.M., C.D. Anderson, R.L. Van Tassell, D.M. Lyerly, and T.D. Wilkins. 1993. Purification and characterization of Clostridium difficile glutamate dehydrogenase. Arch. Biochem. Biophys. 300:483-488.
3. Azeddoug, H., J. Hubert, and G. Reysset. 1992. Stable inheritance of shuttle vectors based on plasmid pIM13 in a mutant strain of Clostridium acetobutylicum. J. Gen. Microbiol. 138:1371-1378.
4. Braibant, M., L. Guilloteau, and M.S. Zygmunt. 2002. Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family. Antimicrob. Agents. Chemother. 46:3050-3053.
5. Brown, M.H., I.T. Paulsen, and R.A. Skurray. 1999. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 31:394-395.
6. Chen, J., Y. Morita, M.N. Huda, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2002. VmrA, a member of a novel class of Na(+)-coupled multidrug efflux pumps from Vibrio parahaemolyticus. J. Bacteriol. 184:572-576.
7. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2002. Communiqué 2002. Société Française de Microbiologie, Paris, France.
8. Dubreuil, L. 1993. Sensibilité aux antibiotiques des anaérobies stricts à l'exclusion des Bacteroides du groupe fragilis. Revue Française des Laboratoires. 256:85-90.
9. +-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
10. +-coupled multidrug efflux pump, from Vibrio cholerae non-01. Microbiol. Immunol. 47:419-427.
11. Kelly, C.P., C. Pothoulakis, and J.T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
12. Kyte, J., and R.F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
13. Levy, S.B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92 (Suppl.):65S-71S.
14. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation- cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.
15. Miyamae, S., O. Ueda. F. Yoshimura, J. Hwang, Y. Tanaka, and H. Nikaido. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45:3341-3346.
16. Morita, Y., K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42: 1778-1782.
17. Morita, Y., A. Kataoka, S. Shiota, T. Mizushima, and T. Tsuchiya. 2000. NorM of Vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump. J. Bacteriol. 182:6694-6697.
18. Okusu, H., D. Ma, and H. Nikaido. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178:306-308.
19. Putman, M., H.W. van Veen, and W.N. Konings. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672-693.
20. Rouquette-Loughlin, C., S.A. Dunham, M. Kuhn, J.T. Balthazar, and W.M. Shafer. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185:1101-1106.
21. Trinh, S., V. Briolat, and G. Reysset. 2000. Growth response of Clostridium perfringens to oxidative stress. Anaerobe 6:233-240.